Is there a consistent association between coronary heart disease and ischemic stroke caused by intracranial atherosclerosis?;Existe uma associação consistente entre doença coronária e acidente vascular cerebral isquêmico causado por aterosclerose intracraniana?

Arquivos de Neuro-Psiquiatria

Volumn 71, Issue 5, 2013, Pages 320-326

  Conforto, Adriana B ^a   Leite, Claudia da Costa ^a   Nomura, Cesar H ^a   Bor Seng Shu, Edson ^a   Santos, Raul D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Coronary disease; Intracranial arteriosclerosis; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CHONDROITIN SULFATE; CLOPIDOGREL; HEPARIN; HOMOCYSTEINE; LIPOPROTEIN;

ANGIOCARDIOGRAPHY; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEART DEATH; HEART INFARCTION; HEREDITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; RECURRENT DISEASE; REVIEW; RISK FACTOR;

EID: 84877964492     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20130028     Document Type: Review

References (51)

1. WHO. Burden of Disease Statistics. Geneva, Switzerland: World Health Organization. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_part2.pdf. Last accessed September 5th, 2012.
2. Indicadores e Dados Básicos-Brasil-2009. Disponível em: http://tabnet.datasus.gov.br/cgi/idb2009.
3. Feigin VL, Lawes CCM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 populationbased studies: a systematic review. Lancet Neurol 2009;8:355-369.
4. Cabral NL, Gonçalves ARR, Longo AL, et al. Incidence of stroke subtypes, prognosis and prevalence of risk factors in Joinville, Brazil: a 2-year community based study. J Neurol Neurosurg Psychiatry 2009;80:755-761.
5. Puddu P, Puddu GM, Bastagli L, Massarelli G, Muscari A. Coronary and cerebrovascular atherosclerosis: two aspects of the same disease or two different pathologies? Arch Gerontol Geriatr 1995;20:15-22.
6. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study. Lancet 2010;376:112-123.
7. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): case-control study. Lancet 2004;364:937-952.
8. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001;119:300S-320S.
9. Ay H. Advances in the diagnosis of etiologic subtypes of ischemic stroke. Curr Neurol Neurosci Rep 2010;10:14-20.
10. Yamamoto FI. Ischemic stroke in young adults: an overview of etiological aspects. Arq Neuropsiquiatr 2012;70:462-466.
11. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German Stroke Data Bank. Stroke 2001;32:2559-2566.
12. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008;39:2396-2399.
13. Arenillas JF. Intracranial atherosclerosis: current concepts. Stroke 2011;42(Suppl):S20-S23.
14. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 1995;26:14-22.
15. Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P. Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke 2008;39:1142-1147.
16. Mak W, Cheng TS, Chan KH, Cheung RTF, Ho SL. A possible explanation for the racial difference in distribution of large-arterial cerebrovascular disease; ancestral European settlers evolved genetic resistance to atherosclerosis, but confined to the intracranial arteries. Med Hypotheses 2005;65:637-648.
17. Ciríaco JGM, Leite CC, Martin MGM, et al. Basilar artery occlusive disease in stroke survivors in a multiethnic population. Clin Neurol Neurosurg 2009;112:233-236.
18. Man BL, Fu YP, Chan YY, et al. Long-term outcomes of ischemic stroke patients with concurrent intracranial and extracranial stenoses and ischemic heart disease. Cerebrovasc Dis 2010;29:236-241.
19. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial stenosis. N Engl J Med 2005;352:1305-1316.
20. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993-1003.
21. Hardie K, Hankey GJ, Jamrozik K, Broadhurst R, Anderson C. Ten-year survival after first-ever stroke in the Perth Community Stroke Study. Stroke 2003;34;1842-1846.
22. Anderson CS, Jamrozik KD, Broadhurst RJ, Stewart-Wynne EG. Predicting survival for 1 year among different subtypes of stroke: results from the Perth Community Stroke Study. Stroke 1994;25:1935-1944.
23. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297:1197-1206.
24. Sander D, Carolei A, Diehm C, Hennerici MG. Challenges to the management of high-risk stroke patients with multiple-site occlusive vascular disease. Cerebrovasc Dis 2011;31:315-321.
25. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology 2006; 14:641-646.
26. Touzé E, Varenne O, Chatellier G, et al. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005;36:2748-2755.
27. Amarenco P, Goldstein LB, Sillesen H, et al. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial. Stroke 2010;41:426-430.
28. Fitchett DH, Goodman SG, Langer A. Ischemic stroke: a cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Can J Cardiol 2008;24:705-708.
29. Lackland DT, Elkind MS, D'Agostino R Sr, et al. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43:1998-2027.
30. Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PA, Hauw JJ, Amarenco P. Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke 2007;38:1203-1210.
31. Calvet D, Touzé E, Varenne O, Sablayrolles JL, Weber S, Mas JL. Prevalence of asymptomatic coronary artery disease in ischemic stroke. patients: the PRECORIS study. Stroke 2010;121:1623-1629.
32. Amarenco P, Lavallée PC, Labereuche L, et al. Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke 2011;42:22-29.
33. Adams RJ, Chimowitz MI, Alpers JS, et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the stroke council and the council on clinical cardiology of the American Heart Association/American Stroke Association. Stroke 2003;34:2310-2322.
34. D'Agostino RB, Sr, Grundy, S, Sullivan, LM, Wilson, P, CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-187.
35. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel, III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
36. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481-1492.
37. D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J 2000;139:272-281.
38. Sposito AC, Caramelli B, Fonseca FA. IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology. Arq Bras Cardiol 2007;88(Suppl 1):S2-S19.
39. Feldmann E. Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA): Design of a prospective, multicenter trial of diagnostic tests. Neuroepidemiology 2004;23:23-32.
40. Conforto AB, Ciríaco JGM, Yamamoto FI, et al. Avoiding pitfalls in diagnosing basilar artery occlusive disease: clinical and imaging clues-case report. Sao Paulo Med J 2010;128:171-173.
41. Nakamura M, Imaizumi K, Shigemi U, Nakashima Y, Kikuchi Y. Cerebral atherosclerosis in Japanese. Part 5: relationship between cholesterol deposition and glycosaminoglycans. Stroke 1976;7:594-598.
42. Bang OY, Lee PH, Yoon SR, Lee MA, Joo IS, Huh K. Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry 2005;76:1128-1134.
43. Mathur KS, Kashyap SK, Kumar V. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963;27:929-934.
44. McGarry P, Solberg LA, Guzman MA, Strong JP. Cerebral atherosclerosis in New Orleans. Comparisons of lesions by age, sex, and race. Lab Invest 1985;52:533-539.
45. Santos RD, Nasir K, Rumberger JA, et al. Difference in atherosclerosis burden in different nations and continents assessed by coronary artery calcium. Atherosclerosis 2006;187:378-384.
46. Willey JZ, Rodriguez CJ, Moon YP, et al. Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox. Ann Epidemiol 2012; 22:303-309.
47. Arenillas JF, Candell-Riera J, Romero-Farina G, et al. Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors. Stroke 2005;36:1201-1206.
48. Massot A, Pelegri D, Penalba A, Arenillas J, et al. Lipoproteinassociated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease. Atherosclerosis 2011;218:181-187.
49. Seo W, Yong HS, Koh S, et al. Correlation of coronary artery atherosclerosis with atherosclerosis of the intracranial cerebral artery and the extracranial carotid artery. Eur Neurol 2008;59:292-298.
50. Yoon YE, Chang HJ, Cho I, et al. Incidence of subclinical coronary atherosclerosis in patients with suspected embolic stroke using cardiac computed tomography. Int J Cardiovasc Imaging 2011;27:1035-1044.
51. Hoshino A, Nakamura T, Enomoto S, et al. Prevalence of coronary artery disease in Japanese patients with cerebral infarction impact of metabolic syndrome and intracranial large artery atherosclerosis. Circ J 2008;72:404-408.